Fulgent Genetics (FLGT) Acquisitions (2021 - 2026)

Fulgent Genetics' (FLGT) quarterly Acquisitions came in at $55.6 million in Q1 2026, up 59.11% quarter-over-quarter from $34.9 million in Q4 2022.

Fulgent Genetics (FLGT) Acquisitions (2021 - 2026) Analysis & Trends

Fulgent Genetics has disclosed Acquisitions across 3 years of filings, most recently posting $55.6 million for Q1 2026.

Acquisitions for Q1 2026 came in at $55.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $90.5 million (up 159.11% YoY), and the FY2025 annual result was -$3.8 million, changed N/A from the prior year.
Acquisitions came in at $55.6 million for Q1 2026 at Fulgent Genetics, up from $34.9 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $55.6 million in Q1 2026 to a low of $34.9 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn	144.00 Mn
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn	8.87 Bn
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn	-
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn	-
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn	-
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn	37.00 Mn
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn	-
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn	415.00 Mn
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn	2.24 Mn
10	Fulgent Genetics	574.08 Mn	292.12 Mn	21.49 Mn	55.57 Mn

Download Data